Menu
Recruiting NCT07143110

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

Observational Lung Neoplasms

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Lung Neoplasms. Basic parameters: 18 years — 130 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.

Primary outcome measures

  • Treatment patterns [Time frame: Through study completion, an average of 1 year]
Secondary outcome measures (7)
  • Incidence and prevalence [Time frame: Through study completion, an average of 1 year]
  • Baseline demographic and clinical characteristics [Time frame: Through study completion, an average of 1 year]
  • Overall survival [Time frame: Through study completion, an average of 6 months]
  • Time to/on therapy [Time frame: Through study completion, an average of 6 months]
  • Attrition rates [Time frame: Through study completion, an average of 1 year]
  • Healthcare resource utilization (HCRU) [Time frame: Through study completion, an average of 1 year]
  • Direct healthcare costs [Time frame: Through study completion, an average of 1 year]

Eligibility criteria

Inclusion criteria

  • Patients with lung cancer between January 1, 2018 and end of the Selection Period.
  • Patient is 18 years of age or older on diagnosis date.
  • Patient has at least 12 months of health insurance coverage prior to the diagnosis date.

Exclusion criteria

  • Diagnosed with any other cancer in the 5-year period prior to January 1, 2018.
  • Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis.
  • Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type).
  • Non-Ontario or non-Alberta resident on diagnosis date.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Canada · 2 centers
  • Research Site — Calgary
  • Research Site — Toronto

Identifiers

NCT: NCT07143110 · D133HR00044

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗